Information Provided By: 
Fly News Breaks for September 24, 2018
TMO
Sep 24, 2018 | 06:48 EDT
Barclays analyst Jack Meehan raised his price target for Thermo Fisher Scientific to $275 after hosting meetings with the company's management across Europe. The analyst says he believes, more so than ever, that Thermo Fisher's customer value proposition is resonating in the market. Further, following a period of major consolidation, Thermo's portfolio is tilting toward a faster growth trajectory, Meehan tells investors in a research note. He keeps an Overweight rating on the name.
News For TMO From the Last 2 Days
TMO
Apr 25, 2024 | 08:51 EDT
Deutsche Bank raised the firm's price target on Thermo Fisher to $610 from $600 and keeps a Buy rating on the shares post the Q1 report. The analyst says a solid operational performance drove a strong start to 2024.
TMO
Apr 25, 2024 | 08:29 EDT
TMO
Apr 25, 2024 | 07:32 EDT
TMO
Apr 25, 2024 | 07:03 EDT
TMO
Apr 25, 2024 | 06:31 EDT
TMO
Apr 25, 2024 | 05:12 EDT
Barclays analyst Luke Sergott raised the firm's price target on Thermo Fisher to $615 from $590 and keeps an Equal Weight rating on the shares. The company reported a beat across the board, says the analyst, who sees the business stabilizing.
TMO
Apr 24, 2024 | 08:50 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here
TMO
Apr 24, 2024 | 06:11 EDT
TMO
Apr 24, 2024 | 06:09 EDT
TMO
Apr 24, 2024 | 06:02 EDT
TMO
Apr 24, 2024 | 06:00 EDT
